BLT 0.00% 2.6¢ benitec biopharma limited

rats from a sinking ship, page-23

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    "This stock is still severely overpriced until it has flowing revenues to support the capitalization of $159m."

    Actually willial, according to your reasoning, if we look at Arrowhead as a comparison (which is entirely reasonable), we are severely underpriced.

    Benitec's revenue end 2013 $823,000 - mc $159,000,000
    Arrowhead's revenue end 2013 $300,000 - mc $1,023,000,000

 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.